Hereditary gynecological cancer in the genomic era of medicine

Authors

  • Yasser C. Sullcahuaman Allende Médico Genetista, Staff del Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú; Profesor, Facultad de Medicina Humana, Universidad Peruana Cayetano Heredia, Lima, Perú; Profesor de la Escuela de Medicina, Universidad Peruana de Ciencias Aplicadas, Lima, Perú
  • Miluska Loarte Villarreal Ingeniera especialista en Bioinformática Clínica, Instituto de Investigación Genómica IGENOMICA
  • Mariela Torres Loarte Asesoría genética y especialista en Bioinformática Clínica; Profesora, Escuela de Medicina, Universidad Peruana de Ciencias Aplicadas

DOI:

https://doi.org/10.31403/rpgo.v64i2112

Abstract

Cancer is a genetic disease caused by accumulation of sporadic genetic changes in the tumor tissue, generally after the age of 50. However, 10% to 30% of cases occur before the age of 50, some have a family history of cancer and may have inherited genetic changes that are transmitted from generation to generation and are present since conception. The number of genes identified is more than 80 related to approximately 200 genetic syndromes of predisposition to cancer. The importance of detecting these syndromes in patients and their families is because it allows an accurate diagnosis and prediction of risks and specific controls for each person and family, avoiding illness and death in many cases.

Downloads

Download data is not yet available.

Published

2018-09-28

How to Cite

Sullcahuaman Allende, Y. C., Loarte Villarreal, M., & Torres Loarte, M. (2018). Hereditary gynecological cancer in the genomic era of medicine. The Peruvian Journal of Gynecology and Obstetrics, 64(3), 461–468. https://doi.org/10.31403/rpgo.v64i2112

Issue

Section

Simposio estándares en ginecología oncológica